The congress “Partnership in Clinical Trials” (PCT) will unite again the experts from the pharmaceutical industry and promote the future industrial partnerships. Cyntegrity is participating at PCT in the sessions and discussions about risk-based monitoring (RbM) as a research company, the mission and main focus of which is directly targeted on this topic.
When: On 5th-6th of November 2014
- Embracing new technology such as Risk-based Monitoring
- Examining the impact of new compliance regulations on people, process and spending
- Advancing your patient recruitment
- Successful partnering in risk based monitoring
Book a meeting during the PCT with Cyntegrity’s CEO Artem Andrianov by sending a brief request to: firstname.lastname@example.org